Reumatoloxía
Servicio
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (72)
2024
-
Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings
Ocular Immunology and Inflammation, Vol. 32, Núm. 9, pp. 2159-2169
-
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
Reumatologia Clinica, Vol. 20, Núm. 8, pp. 423-439
2023
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome
Journal of Autoimmunity
-
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Reumatologia Clinica, Vol. 19, Núm. 10, pp. 533-548
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2021
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
-
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts
Frontiers in Immunology, Vol. 12
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium
Scientific Reports, Vol. 10, Núm. 1
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations
Reumatologia Clinica, Vol. 16, Núm. 2P2, pp. 133-148
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics
Reumatologia Clinica, Vol. 15, Núm. 3, pp. 156-164
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
PLoS ONE, Vol. 14, Núm. 2
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1